![]() There are concerns about alloimmunization and future haemolytic disease of the newborn in women of the reproductive age. Ĭlinicians sometimes are confronted with the challenge of transfusing haemorrhaging Rhesus (Rh) D negative patients with Rh D positive blood to save their lives. Rhesus Negative Woman Transfused With Rhesus Positive Blood. Our results suggest that increasing experience of the team is a major factor in improved outcome. However, the procedure may be difficult and requires a team approach with ready access to fetal monitoring and emergency caesarean section. Fetal intravascular transfusion is a highly effective treatment for fetal alloimmunisation and allows pregnancies to continue to term and to be delivered vaginally. Caesarean section was performed during two of the procedures, one because of bleeding from the cord puncture site and one because of tamponade of the umbilical vessels. Three of the deaths occurred in the first five cases. The case survival rate was 80% and the procedure survival rate was 93%. At the time of the initial transfusion, the mean haemoglobin level was 5.8 g/dL (range, 2.5-8.5 g/dL) and six fetuses had signs of hydrops. Sixty intravenous transfusions were performed in 20 pregnancies. In most cases, the fetus was paralysed by intramuscular tubocurarine. Fetal haemoglobin levels were measured before and after each transfusion. Transfusion was by injection of packed cells from Rh-negative donors into the fetal umbilical vein near the site of insertion into the placenta. King Edward Memorial Hospital, Perth, which is the sole tertiary level perinatal centre in Western Australia with a referral base of approximately 25,000 pregnancies each year. ![]() To report the first four years' clinical experience with fetal intravascular blood transfusion for the treatment of fetal haemolytic anaemia in Western Australia. Intrauterine intravascular transfusion for fetal haemolytic anaemia: the Western Australian experience. To further characterize the inflammatory feature of FNHTR, we measured a large panel of inflammatory markers in pre- and posttransfusion plasma. It would be desirable to be able to distinguish fever as a result of febrile non- haemolytic transfusion reactions (FNHTR) from other febrile conditions. Changes in circulating inflammatory markers following febrile non- haemolytic transfusion reactions to leucoreduced red cells ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |